NCAM1 and neoplasm: Therefore, different expression levels of CD56 did not seem to be significantly correlated with NK cell-mediated killing of the tumor target cells used in our analysis; however, very low or no expression of CD56 on tumor cells was likely to affect the cytotoxicity of NK cells.